Skip to content
Tenfell
Awarded contract
Published 04 Nov 2022

TPOXX® Antiviral Treatment (Tecovirimat)

Department of Health and Social Care · London

Key facts

Contract value
£2
Awarded
27 Jul 2022
Contract starts
27 Jul 2022
Contract ends
27 Jul 2023
Procedure
Negotiated procedure without prior publication (above threshold)
Buyer type
Central government

Awarded to

SupplierValue
MERIDIAN MEDICAL TECHNOLOGIES LIMITED£1

Description

The monkeypox virus belongs to a family of viruses called orthopox viruses and the drug Tecovirimat is an antiviral designed specifically to treat viral infections of this kind. In the current outbreak, Tecovirimat has been successfully used to treat patients with the most severe presentations of monkeypox virus infection. This contract is for a small supply of TPOXX® Antiviral Treatment (Tecovirimat) for the treatment of severe cases of Monkeypox in the UK.

Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate the price per dose. Publication of this information would therefore: (i) commercially prejudice the supplier in its ongoing negotiations with other national governments; (ii) commercially prejudice the contracting authority in its ongoing negotiations with other vendors; and (iii) impact fair competition between vendors.

Categories (CPV)

Similar open tenders

About Department of Health and Social Care

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.